Report error Found 65 Enz. Inhib. hit(s) with all data for entry = 11686
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 100nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Rheos Medicines
US Patent
Rheos Medicines
US Patent
Affinity DataIC50: 550nMAssay Description:Inhibitor potency was evaluated by measuring enzymatic activity of full length MALT1 at varying concentrations of compound. The enzymatic assay consi...More data for this Ligand-Target Pair

















































